Form 8-K - Current report:
SEC Accession No. 0001829126-25-001253
Filing Date
2025-02-27
Accepted
2025-02-27 16:05:14
Documents
20
Period of Report
2025-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cyclacel_8k.htm   iXBRL 8-K 80133
2 EXHIBIT 10.1 cyclacel_ex10-1.htm EX-10.1 78156
3 EXHIBIT 10.2 cyclacel_ex10-2.htm EX-10.2 16152
4 EXHIBIT 10.3 cyclacel_ex10-3.htm EX-10.3 21125
5 EXHIBIT 99.1 cyclacel_ex99-1.htm EX-99.1 21627
6 GRAPHIC img_001.jpg GRAPHIC 5777
7 GRAPHIC ex99-1_001.jpg GRAPHIC 6630
  Complete submission text file 0001829126-25-001253.txt   508749

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cycc-20250226.xsd EX-101.SCH 3744
9 XBRL DEFINITION FILE cycc-20250226_def.xml EX-101.DEF 26582
10 XBRL LABEL FILE cycc-20250226_lab.xml EX-101.LAB 36614
11 XBRL PRESENTATION FILE cycc-20250226_pre.xml EX-101.PRE 25206
22 EXTRACTED XBRL INSTANCE DOCUMENT cyclacel_8k_htm.xml XML 5625
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 25678646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)